CuraPhyte Skin Ointment
Natural health product licensed in Canada
- Licence holder
- JAMP Pharma Corporation
- NPN or DIN-HM
- 80016361
- Status
- Active licence
- Licence date
- 4 March 2010
- Revision date
- Not provided
- Form
- Onguent
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Oxyde de zinc Source : Oxyde de zinc | 20 % |
Non-medicinal ingredients
4-hydroxybenzoate de méthyle, Lavande, Extrait de boswellia serrata, Essence de feuilles Melaleuca alternifolia, Aloe Barbadensis Leaf Extract., Parahydroxybenzoate de propyle, Liquid paraffin, Pétrolatum, Lanoline, Huile de foie de requin, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | Not specified | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps relieve minor skin irritations and itching due to poison ivy, poison oak and poison sumac.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80016361
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.